Search | AMCP Learn

RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
The Accelerated Approval Program: Balancing Crucial Patient Access with Timely Evidentiary Needs
Driving Quality in Oncology Medication Use Through Precision Medicine
Unlocking AI's Potential in Managed Care: An Actionable Roadmap
The Fine Print of Affordability: What Employers and PBMs Need to Know About Cost-Shifting Strategies
Beyond the Buzzwords: What We Learned Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance
Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
The Future of Metabolic Health in Managed Care: Population Risk and Financial Impact
Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
Managed Care Perspectives on Achieving Diabetes Treatment Goals Using New Monitoring Technology
AMCP Carolinas - Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
(F1) Bridging the Competency Gap: A Career Development Framework for PharmD Students and Pharmacists Interested in Managed Care
(M1) The Last Mile at Point-of-Sale: Why the Pharmacy Counter Decides Everything Policy and Plan Design Set in Motion
(D1) Optimizing the Use of JAK Inhibitors in Dermatology: Real-World Evidence, Indication Expansion, and Managed Care Strategies for Moderate Disease Management
(R1) The Evolving Role of Patient Experience Data in Formulary and Coverage Decision-Making
(W1) Is Your Organization Ready for AI? A Managed Care Playbook
Tuesday, 10/27 - Sessions from 1:45-2:45pm
(D2) Rare Disease Spotlight: Aligning Medical and Pharmacy Benefits in Neuromuscular Diseases Drugs, Diseases, and the Managed Care Impact
Tuesday, 10/27 - Sessions from 10:15-11:30am
(L2) Federal Legislative and Regulatory Update - Nexus 2026
(M2) Development of High-Impact Algorithms: Unlocking U.S. Payer Data to Improve Patient Outcomes
(R2) Repositioning of Biosimilars: How Can the U.S. Optimize Biosimilar Utilization to Improve Patient Health and Lower Total Cost of Care
(W2) AI in Managed Care Pharmacy: Opportunities, Risks, and Readiness for Decision‑Makers Making the Way for Innovation

Pages